In response to the 2705/13.06.2008 Hellenic Capital Market Committee's letter regarding the announcement that was published yesterday in the Athens Exchange site "Announcement regarding the incorporation of a company in the US" where it was mentioned that "ALAPIS SA announces the incorporation of a company in the United States of America with the corporate name ALAPIS RESEARCH LABORATORIES INC, whose scope is the research and development of generics and other pharmaceuticals. The new company will develop pharma laboratories in Boston Massachusetts. ALAPIS SA is the sole shareholder of the company. Τhe composition of the company's Board is as follows: Haralampos Gavras, President of the Board, Nikolaos Kormpis, Secretary, Periklis Livas: Treasurer", ALAPIS SA informs the investment community that the new company's share capital will amount to euro 50,000.